Response to Aghdassi et al., Letter to the editor “Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava–kava consumption”

Archives of Toxicology

Volumn 89, Issue 11, 2015, Pages 2175-2176

  Stickel, Felix ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Klinik Beau Site Bern   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; IRINOTECAN; KAVA; KAWAIN; XENOBIOTIC AGENT; PLANT MEDICINAL PRODUCT;

ACUTE LIVER FAILURE; ANXIETY; DEPRESSION; DIET SUPPLEMENTATION; EDITORIAL; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GLUCURONOSYLTRANSFERASE 1A7 GENE; HERBAL MEDICINE; HUMAN; LIVER CELL CARCINOMA; LIVER INJURY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; DRUG-INDUCED LIVER INJURY; TOXICITY;

ANIMALS; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; HUMANS; PLANT PREPARATIONS;

EID: 84947612399     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1612-8     Document Type: Editorial

References (10)

1. Aghdassi AA, Kraft M, Domschke W, Lerch MM, Weiss FU (2015) Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava–kava consumption. Arch Toxicol (letter to editor)
2. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521
3. Centers for Disease Control and Prevention (2003) Hepatic toxicity possibly associated with kava-containing products—United States, Germany, and Switzerland. JAMA 289:36–37
4. Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J et al (2009) Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct. Drug Saf 32:55–68
5. Ichikawa W, Uehara K, Minamimura K et al (2015) An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients. Br J Cancer 112:1709–1716
6. Navarro VJ, Barnhart H, Bonkovsky HL et al (2014) Liver injury from herbals and dietary supplements in the U.S. drug-induced liver injury network. Hepatology 60:1399–1408
7. Russmann S, Lauterburg BH, Helbling A (2001) Kava hepatotoxicity. Ann Intern Med 135:68–69
8. Stickel F, Baumüller HM, Seitz KH et al (2003) Hepatitis induced by Kava–Kava (Piper methysticum rhizoma). J Hepatol 39:62–67
9. Vogel A, Kneip S, Barut A et al (2001) Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121:1136–1144
10. Vogel A, Ockenga J, Tukey RH et al (2011) Genotyping of the UDP-glucuronosyltransferase (UGT) 1A7 gene revisited. Gastroenterology 140:1692–1693